JPRN-UMIN000021580已完成2 期
Confirmation of safety of new gastrointestinal peptide Ghrelin in patients with chronic kidney disease - Confirmation of safety of new gastrointestinal peptide Ghrelin in patients with chronic kidney disease
Division of Nephrology, Endocrinology and Metabolism School of Medicine Keio University0 个研究点目标入组 6 人开始时间: 2016年3月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with severe liver dysfunction patients with malignant neoplasm patients with severe infection patients with psycological problems patients who have allergy for wheat,milk and egg patients who plans for pregnancy who are judged to be inappropriate for the study by the attending physician
研究者
相似试验
招募中
1 期
Safety confirmation study for peritoneo-gastrointestinal shunt creatiomalignant diseaserefractory ascitesJPRN-jRCT1032220387Shunsuke Sugawara9
已完成
不适用
The safety and efficacy of a new bowel preparation for colonoscopycandidate for colonoscopyJPRN-UMIN000013103Akita Red Cross Hospital300
尚未招募
不适用
A clinical trial to evaluate to GastroIntestinal protective eFfect of Tegoprazan for utilization of potent P2Y12 inhibitors in patients with Acute Coronary Syndrome (GIFT-ACS trial)Diseases of the circulatory systemKCT0007897Yonsei University Yongin Severance Hospital124
已完成
不适用
Evaluation of gastrointestinal tolerance of a new thickening powder in patients with dysphagiaDysphagiaSigns and SymptomsISRCTN86521801umico Research BV (Netherlands)50
已完成
不适用
The safety and gastro-intestinal tolerance of recombinant human lactoferrin (rhLF) in apparently healthy human volunteersgastro-intestinal tolerancegut health10017977NL-OMON34362Pharming Group24